In conclusion, CSRP3 was shown to bespecifically highly expressed in AF-VHD, with a potential clinical significancein the diagnosis of AF-VHD, which may indicate that CSRP3 is a potentialbiomarker, as well as a promising therapeutic target, for AF-VHD. The gene discussed is CSRP3; the disease is atrial fibrillation.